BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Avian flu virus
,
Valproic acid
,
rs3825942
,
IL1A
,
glucose metabolic process
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD155
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Skeletal muscle psoas
Atrioventricular node
Ciliary ganglion
Superior cervical ganglion
Tongue
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
CD155 in tumor progression and targeted therapy.
CD155 is a putative therapeutic target in medulloblastoma.
CD155 is essential for skeletal muscle regeneration by regulating satellite cell proliferation and d…
Brain metastasis-associated fibroblasts secrete fucosylated PVR/CD155 that induces breast cancer inv…
The IgV domain of the poliovirus receptor alone is immunosuppressive and binds to its receptors with…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CD155 in Bladder Cancer
A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monoth…
INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers
Examining Bioactivity of PVSRIPO in Invasive Breast Cancer
A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors or Lymphoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ